Follow

drugs

leqmebi, fda, alzheimer's, alzheimers treatment, drug, memory, medication

FDA Approves Controversial Alzheimer’s Drug Leqembi

Today, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease. Leqembi is the second of a new category of medications approved for Alzheimer’s disease that target the fundamental pathophysiology of the disease. These medications represent an important advancement in the ongoing fight to effectively treat Alzheimer’s disease. “Alzheimer’s …

FDA Approves Controversial Alzheimer’s Drug Leqembi Read More »

Scroll to Top